Up to a 10% to 20% weight loss, or higher, has been seen with these newer treatments, but some people need to stop treatment because of stomach side effects (nausea, vomiting, diarrhea, constipation and stomach pain)
Once activated, minoxidil sulfate acts as a potassium channel opener, causing hyperpolarization of cell membranes
Yes, you can get next-day appointments at all our branches
Importantly, glucose metabolism and insulin sensitivity were either unchanged or slightly improved, contrasting with the diabetogenic effects of growth hormone
Hi Southsounder, I'm here in the US, east coast, mid atlantic area
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
